Back to Trades
Other4
Keros Therapeutics, Inc.
KROS
Total Value
$3.8M
Company Information
- Company Name
- Keros Therapeutics, Inc.
- Ticker Symbol
- KROS
- CIK
- 0001664710
Insider Information
- Role
- Director
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Dec 18, 2025
- Transaction Date
- Nov 21, 2025
- Accession Number
- 0000947871-25-001085
- Form Type
- 4